Single oral doses of the novel bace inhibitor bi 1181181 significantly reduce concentrations of cerebrospinal fluid amyloid-beta peptides in healthy subjects

Authors
Category Primary study
JournalAlzheimer's and Dementia
Year 2015
This article has no abstract
Epistemonikos ID: 97eeab4d54b03fd72679ec20804efd04e754e9ad
First added on: Feb 07, 2025